POKONZA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Pokonza, and what generic alternatives are available?
Pokonza is a drug marketed by Pharma Res Software and is included in one NDA.
The generic ingredient in POKONZA is potassium chloride. There are two hundred and forty drug master file entries for this compound. Eighty-eight suppliers are listed for this compound. Additional details are available on the potassium chloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pokonza
A generic version of POKONZA was approved as potassium chloride by ACTAVIS LABS FL INC on April 10th, 2002.
Summary for POKONZA
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 3 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in POKONZA? | POKONZA excipients list |
DailyMed Link: | POKONZA at DailyMed |
Pharmacology for POKONZA
Drug Class | Osmotic Laxative Potassium Salt |
Mechanism of Action | Osmotic Activity |
Physiological Effect | Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption |
Anatomical Therapeutic Chemical (ATC) Classes for POKONZA
US Patents and Regulatory Information for POKONZA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pharma Res Software | POKONZA | potassium chloride | FOR SOLUTION;ORAL | 208019-002 | Aug 25, 2023 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |